Why Outsourcing to Integrated Drug Discovery CRO Makes Sense
Pharmaceutical companies are increasingly outsourcing research to other organizations. Assigning an Integrated drug discovery CRO the task of doing the groundwork for formulating a new treatment is a growing trend. More and more biopharmaceutical companies are partnering with research organizations on drug discovery projects.
Why are large corporations that have dedicated
research departments relying on other organizations for the purpose? There are
various factors that encourage pharmacy majors to join hands with
professional drug discovery services. Here we are listing the major
reasons why pharmaceutical enterprises are using external assistance for
research.
1.
Reduce the Costs of Drug Development
Discovering and
developing new and better therapeutics is a cost-intensive process. A study
suggests that the global pharma industry spends more than billions on launching a new drug in the market. Many times, drug
candidates fail at the last stage of the process causing massive losses to the
organizations involved in the development. There are concerns among the
companies about diminishing economic returns. Delegating the initial research
to external drug discovery
laboratories makes better sense
as such agencies have the capacity to devious better in vitro and in vivo
methods. This helps companies save money that they would have had to spend on
making the in-house arrangements.
2.
Access to Specialists and Modern Technologies
Another reason why the
trend has gathered pace is that an integrated drug discovery service
provider has dedicated specialists and cutting edge technology. The
advancements made in the fields of high-throughput screening and combinatorial
chemistry have helped in the identification of better lead molecules and
targets. It is difficult for all companies to create the necessary
infrastructure and hire experts with great expertise in the domain. Partnering
with drug discovery services gives them access to specialists
and sophisticated technologies without incurring prohibitive costs.
3.
Accelerate the Drug Development Process
The initial stages of a
drug discovery process rarely give a hint about the project’s success or
failure. There is always a chance of sustaining losses if the findings are not
promising. A failed project and the subsequent losses can affect the other work
being done by an organization. When the process is outsourced to external drug
discovery laboratories, it helps in mitigating the risks involved in the
research. The pharma company can handle the major functions while the
specialist agency conducts all the processes involved in the research.
Contact
Integral BioSciences- An Efficient Integrated Drug Discovery Service
Provider to Outsource Your Projects
Integral BioSciences
works with major biopharmaceutical companies in the field of small molecule
drug discovery. It enjoys the reputation of providing efficient drug discovery services to all its clients. Think strategically and reduce your
risks by partnering with Integral BioSciences.